Founded in July2011, with personalized diagnosis and treatment of cardiovascular, tumor as thestrategic direction, Wuhan YZY Medical Science and Technology Co., Ltd. (YZYMed) is a high-tech enterprise specializing in the R&D, production andsales of individualized medical diagnostic products. The company hasestablished various technical platforms, including ARMS fluorescencequantitative PCR, multiple fluorescence quantitative PCR, nucleic acid massspectrometry, fluorescence in situ hybridization(FISH) and circulating tumorcell detection, etc. Meanwhile, the self-developed products include moleculardiagnostic products to guide personalized medicine forcardiovascular and cerebrovascular diseases, companion diagnostic products toguide tumor diagnosis and treatment, FISH products and circulating tumor cell(CTC) Autoanalyzer System, all these provide clinical diagnosis basis forprecision medicine.
With a R&D center of 2,000㎡and GMP-accredited industrializedworkshop of 3,200㎡,YZY Medhas successfully developedover 160 genetic diagnostic products and multiple in vitro diagnostic (IVD)devices, among which 15 molecular diagnostic kits have been approved by theNMPA Class III medical device registration and approval, and 110 products havepassed the CE certification.
